Literature DB >> 28991772

Prevalence of Depression, Anxiety and Insomnia in Chronic Kidney Disease Patients and their Co-Relation with the Demographic Variables.

H K Aggarwal1, Deepak Jain1, Geeta Dabas1, R K Yadav1.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is an emerging health problem in both developed and developing countries. Depression, anxiety and sleep disturbances are highly prevalent in patients with chronic disease, but remain undertreated despite significant negative consequences on patients' health. Assessment of key components of mental health early in disease course will help to identify high risk subjects in whom modifying these predictors will help in providing active and healthy life in CKD patients.
METHODS: We did a cross sectional study in 200 patients of CKD stage III to V-D fulfilling the eligibility criteria who were on follow up in a single tertiary care center in the state of Haryana, India. We assessed the prevalence of anxiety, depression and insomnia and their correlation with demographic variables in these patients. The structured questionnaire used in this study gathered information on respondent demographic and disease characteristics, and information obtained from the HADS and PSQI questionnaire. Factors associated with anxiety, depression and insomnia were examined by a multiple logistic regression analysis.
RESULTS: The prevalence of anxiety, depression and insomnia were found to be 71%, 69% and 86.5% respectively. As the CKD stage advanced, the prevalence as well as severity of these parameters increased. Anxiety, depression and sleep quality were found to be significantly correlated to unemployment, low income, low education, urban residence and presence of co-morbidities. The anxiety, depression and insomnia scores were found to have a strong negative correlation with eGFR, hemoglobin, serum calcium (p <0.01) and a positive correlation with TLC, blood urea, serum creatinine and serum phosphate (p <0.05).
CONCLUSION: We observed a high prevalence of anxiety, depression and insomnia in CKD patients. There is a need to develop strategies to accurately identify "high risk" subjects who may benefit from preventive measures before complications occur. By identifying CKD patients with high risk of developing these mental health related issues, healthcare provider may be better able to ensure the provision of appropriate rehabilitation to this population.

Entities:  

Keywords:  Chronic kidney disease; anxiety; depression; insomnia

Mesh:

Year:  2017        PMID: 28991772     DOI: 10.1515/prilozi-2017-0020

Source DB:  PubMed          Journal:  Pril (Makedon Akad Nauk Umet Odd Med Nauki)        ISSN: 1857-9345


  9 in total

1.  Effect of novel oral anticoagulants on Hospital Anxiety and Depression Scale scores.

Authors:  K Cosansu; C M Ureyen; S Yılmaz
Journal:  Herz       Date:  2019-06-24       Impact factor: 1.443

2.  Potential Depression and Associated Factors Among Individuals Undergoing Dialysis: A Hospital-Based Cross-Sectional Survey in Central Kerala.

Authors:  K R Neenumol; Jissa V Thulaseedharan
Journal:  Indian J Nephrol       Date:  2022-01-05

3.  Prevelance of depression and anxiety with their effect on quality of life in chronic kidney disease patients.

Authors:  Sameeha Alshelleh; Abdullah Alhouri; Alaa Taifour; Bilal Abu-Hussein; Faris Alwreikat; Mohammad Abdelghani; Muhannad Badran; Yousef Al-Asa'd; Hussein Alhawari; Ashraf O Oweis
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

4.  The bidirectional association between depressive symptoms, assessed by the HADS, and albuminuria-A longitudinal population-based cohort study with repeated measures from the HUNT2 and HUNT3 Study.

Authors:  Lise Tuset Gustad; Anna Marie Holand; Torfinn Hynnekleiv; Ottar Bjerkeset; Michael Berk; Solfrid Romundstad
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

5.  How Are Albertans "Adjusting to and Coping With" Dialysis? A Cross-Sectional Survey.

Authors:  Kara Schick-Makaroff; Charlotte Berendonk; Jordan Overwater; Laura Streith; Loretta Lee; Manuel Escoto; Daniel Cukor; Scott Klarenbach; Richard Sawatzky
Journal:  Can J Kidney Health Dis       Date:  2022-08-23

6.  Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: a mixed methods approach.

Authors:  Marcela Agudelo-Botero; María Cecilia González-Robledo; Hortensia Reyes-Morales; Liliana Giraldo-Rodríguez; Mario Rojas-Russell; Dolores Mino-León; Dayan Irene Ocampo-Morales; Rafael Valdez-Ortiz
Journal:  Int J Equity Health       Date:  2020-06-08

7.  Depression Impairs Level of Functioning in Chronic Kidney Disease Inpatients: A Case-Control Study.

Authors:  Anuj Virani; Rushi P Shah; Goher Haneef; Asma T Khan; Caroline C Dias; Kristal N Pereira; Siddharth Gupta; Prerna Sharma
Journal:  Cureus       Date:  2021-06-29

8.  Prevalence and association of depression with uremia in dialysis population: a retrospective cohort analysis.

Authors:  Jin Liu; Fan Zhang; Yujie Wang; Dan Wu
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

9.  Genetically Predicted Insomnia in Relation to 14 Cardiovascular Conditions and 17 Cardiometabolic Risk Factors: A Mendelian Randomization Study.

Authors:  Xinhui Liu; Chuanbao Li; Xiaoru Sun; Yuanyuan Yu; Shucheng Si; Lei Hou; Ran Yan; Yifan Yu; Mingzhuo Li; Hongkai Li; Fuzhong Xue
Journal:  J Am Heart Assoc       Date:  2021-07-28       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.